Abstract
Purpose. The purpose of this study was to characterize the function of multidrug resistance-associated proteins (MRPs) (or MRP-like organic anion transport systems) in the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB) using both an in vitro BBB model and an in vivo microdialysis model.
Methods. In vitro functional studies were performed using bovine brain microvessel endothelial cells (BBMEC). The accumulation of fluorescein, an anionic fluorescent dye, in BBMEC was determined with and without the presence of inhibitors of various efflux transport proteins. In vivo microdialysis simultaneously monitored fluorescein concentrations in cortical extracellular fluid and cerebrospinal fluid. The effect of probenecid on the in vivo distribution of fluorescein was studied using a balanced crossover design in the rat.
Results. In vitro experiments showed that probenecid, indomethacin, LY-329146, and all MRP inhibitors significantly increased (two- to threefold) the accumulation of fluorescein in BBMEC, whereas LY-335979, a P-gp inhibitor, had no effect on the accumulation of fluorescein. Probenecid significantly increased fluorescein plasma concentration and the plasma free fraction in vivo. The distribution of fluorescein across the BBB and BCSFB was enhanced by 2.2- and 1.9-fold, respectively, when probenecid was coadministered, even after correction for increased fluorescein plasma concentrations and free fraction.
Conclusions. These results demonstrate that MRPs or MRP-like transport system(s) may play an important role in fluorescein distribution across both BBB and BCSFB. This study showed that microdialysis proved to be a powerful in vivo technique for the study of transport systems in the central nervous system, and in vitro/in vivo correlations are possible using these model systems.
Similar content being viewed by others
REFERENCES
R. Spector and E. J. Goetzl. Leukotriene C4 transport and metabolism in the central nervous system. J. Neurochem. 46:1308-1312 (1986).
B. M. Emanuelsson, L. Paalzow, and M. Sunzel. Probenecid-induced accumulation of 5-hydroxyindoleacetic acid and homo-vanillic acid in rat brain. J. Pharm Pharmacol. 39:705-710 (1987).
C. S. Kim and J. B. Pritchard. Transport of 2,4,5-trichlorophenoxyacetic acid across the blood-cerebrospinal fluid barrier of the rabbit. J. Pharmcol. Exp. Ther. 267:751-757 (1993).
S. L. Wong, K. van Belle, and R. J. Sawchuk. Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid/cerebrospinal fluid in the rabbit: investigation of the inhibitory effect of probenecid utilizing microdialysis. J. Pharmacol. Exp. Ther. 264:899-909 (1993).
A. Regina, A. Koman, M. Piciotti, B. E. Hafny, M. S. Center, R. Bergmann, P. O. Couraud, and F. Roux. Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J. Neurochem. 71:705-715 (1998).
H. Huai-Yun, D. T. Secrest, S. M. Karen, D. Carney, C. Brandquist, W.F. Elmquist, and D. W. Miller. Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. Biochem. Biophys. Res. Commun. 243:816-820 (1998).
V. V. Rao, J. L. Dahlheimer, M. E. Bardgett, A. Z. Snyder, R. A. Finch, A. Sartorelli, and D. Piwnica-Worms. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc. Natl. Acad. Sci. USA 96:3900-3905 (1999).
R. H. Angeletti, P. M. Novikoff, S. R. Juvvadi, J. M. Fritschy, P. J. Meier, and A.W. Wolkoff. The choroid plexus epithelium is the site of the organic anion transport protein in the brain. Proc. Natl. Acad. Sci. USA 94:283-286 (1997).
J. I. Nishino, H. Suzuki, D. Sugiyama, T. Kitazawa, K. Ito, M. Hanano, and Y. Sugiyama. Transepithelial transport of organic anions across the choroid plexus: possible involvement of organic anion transporter and multidrug resistance-associated protein. J. Pharmcol. Exp. Ther. 290:289-294 (1999).
B. Gao, B. Stieger, B. Noe, J. M. Fritschy, and P. J. Meier. Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain. J. Histochem. Cytochem. 47:1255-1264 (1999).
R. L. Leino, D. Z. Gerhart, and L. R. Drewes. Monocarboxylate transporter (MCT1) abundance in brains of suckling and adult rats: a quantitative electron microscopic immunogold study. Brain. Res. Dev. Brain. Res. 113:47-54 (1999).
M. Kool, M. de Haas, G. L. Scheffer, R. J. Sheper, M. J. T. van Eijk, J. A. Juijn, F. Baas, and P. Borst. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57:3537-3547 (1997).
P. Borst, R. Evers, M. Kool, and J. Wijnholds. The multidrug resistance protein family. Biochim. Biophys. Acta. 1461:347-357 (1999).
M. A. McAleer, M. A. Breen, N. L. White, and N. Mattews. pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but dose not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells. J. Biol. Chem. 274:23541-23548 (1999).
Y. Zhang, H. Han, W. F. Elmquist, and D. W. Miller. Expression of multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Res. 876:148-153 (2000).
H. Suzuki. Analysis of xenobiotic detoxification system mediated by efflux transporters. Yakugaku Zasshi 119:822-834 (1999).
H. Gutmann, M. Torok, G. Fricker, J. Huwyler, C. Beglinger, and J. Drewe. Modulation of multidrug resistance protein expression in porcine brain capillary endothelial cells in vitro. Drug Metab. Dispos. 27:937-941 (1999).
B. El Hafny, O. Chappey, M. Piciotti, M. Debray, B. Boval, and F. Roux. Modulation of P-glycoprotein activity by glial factors and retinoic acid in an immortalized rat brain microvessel endothelial cell line. Neurosci. Lett. 236:107-111 (1997).
W. F. Elmquist and R. J. Sawchuk. Application of microdialysis in pharmacokinetic studies. Pharm. Res. 14:267-288 (1997).
J. H. Hooijberg, H. J. Broxterman, M. Kool, Y. G. Assaraf, G. J. Peters, P. Noordhuis, R. J. Scheper, P. Borst, H. M. Pinedo, and G. Jansen. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res. 59:2532-2535 (1999).
D. W. Miller, K. L. Audus, and R. T. Borchardt. Application of cultured endothelial cells of the brain mirovasculature in the study of the blood-brain barrier. J. Tissue Cult. Meth. 14:217-224 (1992).
O. H. Lowry, N. J. Rosenbrough, A. L. Farr, and R. J. Randal. Protein measurement with folin phenol reagent. J. Biol. Chem. 193:265-275 (1951).
H. Yang, Q. Wang, and W. F. Elmquist. Fluconazole distribution to the brain: a crossover study in freely-moving rats using in vivo microdialysis. Pharm. Res. 13:1570-1575 (1996).
Y. Wang, S. L. Wong, and R. J. Sawchuk. Microdialysis calibration using retrodialysis and zero-net flux: application to a study of the distribution of zidovudine to rabbit cerebrospinal fluid and thalamus. Pharm. Res. 10:1411-1419 (1993).
R. E. Galinsky, K. K. Flaharty, B. L. Hoesterey, and B. D. Anderson. Probenecid enhances central nervous system uptake of 2′,3′-dideoxyinosine by inhibiting cerebrospinal fluid efflux. J. Pharmcol. Exp. Ther. 257:972-978 (1991).
A.H. Dantzig, R.L. Shepard, K.L. Law, L. Tabas, S. Pratt, J.S. Gillespie, S.N. Binkley, M.T. Kuhfeld, J.J. Starling, and S.A. Wrighton. Selectivity of the multidrug resistance modulator, LY335979, for p-glycoprotein and effect on cyctochrome P-450 activities. J. Pharmcol. Exp. Ther. 290:854-862 (1999).
B. H. Norman, A. H. Dantzig, K. L. Hauser, J. S. Kroin, K. L. Law, A. D. Palkowitz, R. L. Shepard, J. P. Sluka, J. J. Starling, L. L. Tabas, and M. A. Winter. Novel inhibitors of the multidrug resistance-associated protein (MRP). Annu. Meet. Am. Assoc. Cancer Res. (1997).
M. P. Draper, R. L. Martell, and S. B. Levy. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressed MRP, but not P-glycoprotein. Br. J. Cancer. 75:810-815 (1997).
H. Sun, P. Bungay, and W. F. Elmquist. The influence of capillary efflux inhibition on microdialysis probe recovery. J. Pharmacol. Exp. Therap. 297:991-1000 (2001).
I. Leier, G. Jedlitschky, U. Buchholz, S. P. Cole, R. G. Deeley, and D. Keppler. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 269:27807-27810 (1994).
H. Sun, D. R. Johnson, R. A. Finch, A. C. Sartorelli, D. W. Miller, and W. F. Elmquist. Transport of fluorescein in MDCKII-MRP1 transfected cells and mrp1-knockout mice. Biochem. Biophys. Res. Commun. 284:863-869 (2001).
B. M. Emanuelsson and L. Paalzow. Dose-dependent pharmacokinetics of probenecid in the rat. Biopharm. Drug Disposit. 9:59-70 (1988).
J. Wijnholds, E. C. M. de Lange, G. L. Scheffer, D. J. van den Berg, C. A. A. M. Mol, M. van der Valk, A. H. Schinkel, R. J. Scheper, D. D. Breimer, and P. Borst. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J. Clin. Invest. 105:279-285 (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sun, H., Miller, D.W. & Elmquist, W.F. Effect of Probenecid on Fluorescein Transport in the Central Nervous System Using In Vitro and In Vivo Models. Pharm Res 18, 1542–1549 (2001). https://doi.org/10.1023/A:1013074229576
Issue Date:
DOI: https://doi.org/10.1023/A:1013074229576